Genetic landscape of pulmonary langerhans cell histiocytosis

F. Jouenne (Paris, France), G. Lorillon (Paris, France), C. Laurent-Issartel (Paris, France), A. Sadoux (Paris, France), V. Meignin (Paris, France), C. Leschi (Paris, France), E. Bugnet (Paris, France), S. Mourah (Paris, France), A. Tazi (Paris, France)

Source: International Congress 2018 – Progress in rare interstitial lung diseases
Session: Progress in rare interstitial lung diseases
Session type: Oral Presentation
Number: 3781
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Jouenne (Paris, France), G. Lorillon (Paris, France), C. Laurent-Issartel (Paris, France), A. Sadoux (Paris, France), V. Meignin (Paris, France), C. Leschi (Paris, France), E. Bugnet (Paris, France), S. Mourah (Paris, France), A. Tazi (Paris, France). Genetic landscape of pulmonary langerhans cell histiocytosis. 3781

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic landscape of adult Langerhans cell histiocytosis with lung involvement
Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019
Year: 2020



Pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008



Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Pulmonary Langerhans' cell histiocytosis
Source: Eur Respir Mon; 2009: 46: 155–175
Year: 2009

How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017



Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020



Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016

Langerhans cell histiocytosis: is it an ILD?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021


Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170042; 10.1183/16000617.0042-2017
Year: 2017



Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Lung transplantation for pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Lung function progression in Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012


Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019



Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Pneumothorax in patients with Langerhans cell histiocytosis
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017

Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017
Year: 2018



Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis
Source: Eur Respir J 2016; 47:1785-1796
Year: 2016